VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 59 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $125,673 | +96.5% | 16,300 | +55.5% | 0.01% | +66.7% |
Q4 2022 | $63,947 | -58.5% | 10,483 | -59.7% | 0.00% | -50.0% |
Q3 2022 | $154,000 | -27.0% | 26,000 | -27.3% | 0.01% | -33.3% |
Q2 2022 | $211,000 | -24.9% | 35,778 | -3.2% | 0.01% | -25.0% |
Q1 2022 | $281,000 | +462.0% | 36,947 | +98.6% | 0.01% | +300.0% |
Q4 2021 | $50,000 | – | 18,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |